Hamster preproglucagon contains the sequence of glucagon and two related peptides
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucagon is a 29-amino acid polypeptide hormone synthesized by the A cells of the endocrine pancreas. Its primary site of action is the liver where it stimulates glycogenolysis, gluconeogenesis and ketogenesis. In mammals, biosynthetic studies have shown that glucagon is derived from a precursor of molecular weight (Mr) approximately 18,000 which is five to six times larger than glucagon. Glucagon-containing polypeptides and immunoreactants of various sizes have also been described from stomach, intestine, brain and salivary gland. Here, we have determined the structure of hamster pancreatic preproglucagon from the sequence of its cDNA. This 180-amino acid precursor contains the sequence of glucagon and two glucagon-like polypeptides arranged in tandem. The precursor also contains the sequences of several non-pancreatic glucagon-containing polypeptides which suggests that, in mammals, both pancreatic and non-pancreatic glucagon and glucagon-containing polypeptides may be derived from a common precursor by tissue-specific processing. We have tentatively identified each of the glucagon-like immunoreactants which have been described with respect to the sequence of proglucagon and have proposed a scheme for the processing of pancreatic proglucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“This highlighted for the first time that supplemental GLP-1R/GIPR co-agonism could greatly outperform GLP-1R mono-agonism, to achieve greater weight loss and elicit further improvements in glucose homeostasis48.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“MAR709 successfully completed Phase 1 clinical trials with good tolerability48,124,125, concomitant with a meaningful reduction in body weight and HbA1c levels in subjects with T2D48,125.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“There are two notable unimolecular GLP-1R/GIPR co-agonist peptides that have been preclinically and clinically most characterized to display enhanced glucose-lowering potential, superior weight loss and appetite suppression, when evaluated with comparable GLP-1R agonists.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
3′ Non-coding region sequences in eukaryotic messenger RNA
Proudfoot, N. J., & Brownlee, G. G. (1976) · Nature · doi:10.1038/263211a0 · Cited by 2,968
Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis
Beaucage, S. L., & Caruthers, M. H. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)90461-7 · Cited by 1,993
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,294
The sequence 5′-AAUAAA-3′ forms part of the recognition site for polyadenylation of late SV40 mRNAs
Fitzgerald, M. (1981) · Cell · doi:10.1016/0092-8674(81)90521-3 · Cited by 776
Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA
Comb, M., Seeburg, P. H., Adelman, J., Eiden, L., & Herbert, E. (1982) · Nature · doi:10.1038/295663a0 · Cited by 679
Research works printed but not linked: 1
- Unger, R.H. & Orei, L. (eds) Glucagon. Physiology, Pathophysiology and Morphology of the Pancreatic A-Cell (Elsevier, New York, 1981).
Cited by
Items 101–200 of 645
Microscopic Anatomy of the Human Islet of Langerhans
Veld, P. I. '., & Marichal, M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_1 · Cited by 173
“Other cleavage products that can be derived from the precursor are GLP-1, GLP-2, and glicentin [ 27 , 28].”
BackgroundMolecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
Russell-Jones, D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.018 · Cited by 137
Bak, M. J., Albrechtsen, N. W., Pedersen, J., Hartmann, B., Christensen, M., Vilsbøll, T., Knop, F. K., Deacon, C. F., Dragsted, L. O., & Holst, J. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0941 · Cited by 136
Jin, T., & Drucker, D. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.19 · Cited by 140
“The proglucagon gene is expressed in the A cells of pancreatic islets, selected neurons of the hypothalamus and brain stem, and enteroendocrine cells of the small and large intestines (1, 5, 6).”
BackgroundKilimnik, G., Kim, A., Steiner, D. F., Friedman, T. C., & Hara, M. (2010) · Islets · doi:10.4161/isl.2.3.11396 · Cited by 137
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives
Meier, J. J., Gallwitz, B., Schmidt, W. E., & Nauck, M. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01434-6 · Cited by 146
Golgi/granule processing of peptide hormone and neuropeptide precursors: A minireview
Steiner, D. F., Docherty, K., & Carroll, R. (1984) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240240204 · Cited by 133
Glucagon‐like Peptide‐2 and the Regulation of Intestinal Growth and Function
Brubaker, P. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170055 · Cited by 138
Luginbuhl, K. M., Schaal, J. L., Umstead, B. R., Mastria, E. M., Li, X., Banskota, S., Arnold, S., Feinglos, M. N., D’Alessio, D. A., & Chilkoti, A. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0078 · Cited by 130
“The parent peptide, GLP1, is a 31-amino acid incretin hormone derived from post-translational processing of the proglucagon gene 4,5 .”
Holst, J. J. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00157-5 · Cited by 146
DPP-4 Inhibition and the Path to Clinical Proof
Åhrén, B. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00376 · Cited by 138
“This finding was published in April, 1983, using the hamster as a model (11) and, in July, 1983, using the human proglucaon sequence (12).”
MethodGlucagon-like peptide 2 function in domestic animals
Burrin, D. G., Stoll, B., & Guan, X. (2003) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(02)00210-2 · Cited by 146
“However, a series of developments in the early 1980s, including the cloning of the proglucagon cDNA and the isolation and sequencing of glicentin from pig intestinal tissue, led to the eventual identification of the amino acid sequence of the peptide fragments derived from the proglucagon gene in the intestine, one of…”
BackgroundTransforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Du, H., Meng, X., Yao, Y., & Xu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1033479 · Cited by 125
“However, neither GLP-1 nor GLP-2 were active on insulin secretion, but a truncated version of GLP-1 was subsequently found to enhance insulin secretion in various experimental models and human studies (88–90).”
BackgroundIdentical mRNA for preproglucagon in pancreas and gut
NOVAK, U., WILKS, A., BUELL, G., & McEWEN, S. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11162.x · Cited by 124
Belsham, D. D., Fick, L. J., Dalvi, P. S., Centeno, M.-L., Chalmers, J. A., Lee, P. K. P., Wang, Y., Drucker, D. J., & Koletar, M. M. (2009) · The FASEB Journal · doi:10.1096/fj.09-133454 · Cited by 120
“several others in the -cells of the pancreatic islets, the intestinal L cells, and the brain (30, 31).”
BackgroundGut adaptation and the glucagon-like peptides
Drucker, D. J. (2002) · Gut · doi:10.1136/gut.50.3.428 · Cited by 121
Glucagon-like peptide-1 (GLP-1): A gut hormone of potential interest in the treatment of diabetes
Ahrén, B. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199808)20:8<642::aid-bies7>3.0.co;2-k · Cited by 125
Raufman, J. P., Singh, L., Singh, G., & Eng, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36628-1 · Cited by 122
Ducroc, R., Guilmeau, S., Akasbi, K., Devaud, H., Buyse, M., & Bado, A. (2005) · Diabetes · doi:10.2337/diabetes.54.2.348 · Cited by 112
“Thus, glucose-dependent insulinotropic polypeptide produced by the duodeno-jejunum endocrine K-cells (30) and GLP-2 from pro-glucagon in endocrine L-cells (31) is able to upregulate SGLT-1 transport activity in vivo, leading to an increased intestinal absorption of glucose (21,22).”
BackgroundStructure of the human ghicagon gene
White, J. W., & Saunders, G. F. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.12.4719 · Cited by 118
Structure of the Human Vasoactive Intestinal Polypeptide Gene
Tsukada, T., Horovitch, S. J., Montminy, M., Mandel, G., & Goodman, R. H. (1985) · DNA · doi:10.1089/dna.1985.4.293 · Cited by 124
“Because VIP, glucagon, and growth hormone releasing factor are derived from separate precursors (Bell et al, 1983; Itoh et al, 1983; Mayo et al, 1983), VIP must be part of a multigene family.”
Patzelt, C., & Schiltz, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.16.5007 · Cited by 118
Laherty, C. D., O'Rourke, K., Wolf, F. W., Katz, R., Seldin, M. F., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50727-x · Cited by 115
Böttcher, G., Alumets, J., Håkanson, R., & Sundler, F. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90046-7 · Cited by 114
Human glucagon‐like peptides 1 and 2 activate rat brain adenylate cyclase
Hoosein, N. M., & Gurd, R. S. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81245-4 · Cited by 113
Green, B., Gault, V., O'Harte, F., & Flatt, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382774 · Cited by 111
“Following cloning of the bovine [8], hamster [9], rat [10] and human [11] preproglucagon genes, it was realised that anglerfish GRP-1 was a homologue of GLP-1, encoded in mammalian genes.”
BackgroundNagell, C. F., Wettergren, A., Pedersen, J. F., Mortensen, D., & Holst, J. J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004424 · Cited by 108
“and GLP-2 (glucagon-like peptide-2) in the early 1980s interest has been focused on GLP-1 (1, 2).”
BackgroundIdentification of glucagon receptors in rat brain.
Hoosein, N. M., & Gurd, R. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4368 · Cited by 110
Zarrinpar, A., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 103
Hussain, M. A., Lee, J., Miller, C. P., & Habener, J. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7186 · Cited by 105
The Origin and Understanding of the Incretin Concept
Rehfeld, J. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00387 · Cited by 102
Sørensen, L. B., Flint, A., Raben, A., Hartmann, B., Holst, J. J., & Astrup, A. V. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802247 · Cited by 107
Gut hormones and appetite control
Hameed, S., Dhillo, W., & Bloom, Sr. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01492.x · Cited by 98
“Its precursor pre-proglucagon is processed by prohormone convertase 1 and 2, which differentially produce glucagon, GLP-1, glucagon-like peptide-2 and OXM depending on the site of synthesis (Bell et al, 1983).”
Drucker, D. J., Mojsov, S., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67561-1 · Cited by 103
Fehmann, H. C., & Habener, J. F. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80182-3 · Cited by 101
The glucagon superfamily: Precursor structure and gene organization
Bell, G. I. (1986) · Peptides · doi:10.1016/0196-9781(86)90160-9 · Cited by 118
Self-citationGlucagon-like peptides 1 and 2 in health and disease: A review
Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.014 · Cited by 100
Changes in gut hormones after bariatric surgery
Vincent, R. P., & Le Roux, C. W. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03164.x · Cited by 100
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 112
Control of insulin secretion by GLP-1
Jones, B. J., Bloom, S. R., Buenaventura, T., Tomás, A., & Rutter, G. A. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.013 · Cited by 105
Hui, H., Zhao, X., & Perfetti, R. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.553 · Cited by 97
“The preproglucagon gene was cloned by two independent groups in the mideighties [1,2].”
MethodDrucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7386 · Cited by 97
Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus
Kreymann, B., Ghatei, M. A., Burnet, P. W. J., Williams, G., Kanse, S. M., Diani, A. R., & Bloom, S. R. (1989) · Brain Research · doi:10.1016/0006-8993(89)90628-8 · Cited by 99
Incretins and the development of type 2 diabetes
Meier, J. J., & Nauck, M. A. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0034-7 · Cited by 105
Molecular evolution of proglucagon
Irwin, D. M. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00232-9 · Cited by 105
Mechanisms underlying proglucagon gene expression
Jin, T. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0085 · Cited by 91
Meier, J. J., Deacon, C. F., Schmidt, W. E., Holst, J. J., & Nauck, M. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0598-z · Cited by 102
Lipolytic action of glucagon-like peptides in isolated rat adipocytes
Ruiz-Grande, C., Alarcón, C., Mérida, E., & Valverde, I. (1992) · Peptides · doi:10.1016/0196-9781(92)90134-o · Cited by 89
Structure and Pancreatic Expression of the Insulin and Glucagon Genes*
Philippé, J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-3-252 · Cited by 89
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon
Mallat, A., Pavoine, C., Dufour, M., Lotersztajn, S., BATAILLE, D., & Pecker, F. (1987) · Nature · doi:10.1038/325620a0 · Cited by 93
Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery
Malik, S., Mitchell, J. E., Steffen, K., Engel, S., Wiisanen, R., Garcia, L., & Malik, S. A. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.07.003 · Cited by 86
“In 1983, Bell and colleagues [48] identified GLP-1 as a cleavage product of the pre-proglucagon gene, and since then it has been shown to function as an even more potent glucose-dependent incretin than GIP [49,50].”
BackgroundIsolation and structures of coho salmon (Oncorhynchus kisutch) glucagon and glucagon-like peptide
Plisetskaya, E. M., POLLOCK, H. G., Rouse, J. B., Hamilton, J. W., KIMMEL, J. R., & Gorbman, A. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90205-3 · Cited by 89
Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives
Jin, T., & Weng, J. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00069.2016 · Cited by 83
“GLP-1 is encoded by the proglucagon gene (Gcg), which is expressed in pancreatic islet -cells, the gut endocrine L cells, and certain neuronal cells in the brain stem (8, 28, 55, 58, 62, 63).”
BackgroundOxyntomodulin: actions and role in diabetes
Holst, J. J., Albrechtsen, N. J. W., Gabe, M. B. N., & Rosenkilde, M. M. (2018) · Peptides · doi:10.1016/j.peptides.2017.09.018 · Cited by 86
“The subsequent cloning of the cDNA encoding the full proglucagon molecule confirmed this hypothesis [10].”
What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?
Kuhre, R. E., Deacon, C. F., Holst, J. J., & Petersen, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.694284 · Cited by 78
“Which Peptide Are Present in L-Cells? L-cells are mainly classified by their production of the hormone precursor, proglucagon – a 160 amino acid pro-peptide encoded by the proglucagon gene (33), located on chromosome 37, 2q36 (2).”
BackgroundPeptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Deacon, C. F. (2018) · Peptides · doi:10.1016/j.peptides.2017.10.011 · Cited by 89
“As well as the sequence of glucagon itself, the proglucagon gene was found to code for two additional sequences which bore strong homology to glucagon, and the existence of two related peptides, GLP-1 and GLP-2, was predicted [2].”
Fehmann, H. C., Jiang, J., Schweinfurth, J., Wheeler, M. B., BOYD, A. E., & Göke, B. (1994) · Peptides · doi:10.1016/0196-9781(94)90204-6 · Cited by 93
Furuse, M., Matsumoto, M., Mori, R., Sugahara, K., Kano, K., & Hasegawa, S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00623-9 · Cited by 88
Proglucagon processing in islet and intestinal cell lines
Tucker, J. D., Dhanvantari, S., & Brubaker, P. L. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(95)00167-0 · Cited by 106
Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain
UTTENTHAL, L. O., Tolédano, A., & Blázquez, E. (1992) · Neuropeptides · doi:10.1016/0143-4179(92)90036-v · Cited by 96
KAWAI, K., SUZUKI, S., OHASHI, S., MUKAI, H., OHMORI, H., MURAYAMA, Y., & YAMASHITA, K. (1989) · Endocrinology · doi:10.1210/endo-124-4-1768 · Cited by 85
Rountree, D. B., Ulshen, M. H., Selub, S. E., Fuller, C. R., Bloom, S. R., Ghatei, M. A., & Lund, P. K. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90835-m · Cited by 84
Boone, C. M., Bussey, H., Greene, D., Thomas, D. Y., & Vernet, T. (1986) · Cell · doi:10.1016/0092-8674(86)90864-0 · Cited by 83
“, 1984), or they can participate in related metabolic processes (Bell et al., 1983), or they can even directly interact in complexes (Land et al.”
BackgroundStructure and expression of the gene encoding the vasoactive intestinal peptide precursor.
Linder, S., Barkhem, T., Norberg, Å., Persson, H., Schalling, M., Hökfelt, T. G. M., & Magnusson, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.605 · Cited by 82
Fiocca, R., Rindi, G., Capella, C., Grimelius, L., Polak, J. M., Schwartz, T. W., Yanaihara, N., & Solcia, E. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90029-2 · Cited by 82
Isolation and structures of glucagon and glucagon-like peptide from catfish pancreas.
Andrews, P., & Ronner, P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89208-0 · Cited by 82
Striking the balance: GLP-1/glucagon co-agonism as a treatment strategy for obesity
Hope, D. C. D., Vincent, M. L., & Tan, T. M. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735019 · Cited by 81
“Beyond the protein-based methodologies used to characterise glicentin, GRPP and oxyntomodulin, the increased capability to sequence genes at the time led to the first sequence of mammalian preproglucagon (15).”
MethodGLP-1 Effects on Islets: Hormonal, Neuronal, or Paracrine?
Donath, M. Y., & Burcelin, R. (2013) · Diabetes Care · doi:10.2337/dcs13-2015 · Cited by 79
“(9-36)amide by dipeptidyl peptidase IV in”
The effects of dual GLP-1/GIP receptor agonism on glucagon secretion-A Review
Mathiesen, D. S., Bagger, J. I., Bergmann, N. C., Lund, A., Christensen, M. B., Vilsbøll, T., & Knop, F. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174092 · Cited by 80
“Glucagon and the glucagon-like peptides (GLP-1 and glucagon-like peptide 2 (GLP-2)) originate from tissue specific processing of proglucagon (their common precursor encoded by the glucagon gene) in the pancreas and the gastrointestinal tract, respectively [22].”
BackgroundYang, J., Campitelli, J., Hu, G., Lin, Y., Luo, J. J., & Xue, C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.040 · Cited by 94
Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon
Rouillé, Y., Bianchi, M., Irminger, J.-C., & Halban, P. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00892-2 · Cited by 80
Glucagon gene 5'-flanking sequences promote islet cell-specific gene transcription.
Drucker, D. J., Philippé, J., Jepeal, L. I., & Habener, J. F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47777-0 · Cited by 87
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
Hjørne, A. P., Modvig, I. M., & Holst, J. J. (2022) · Metabolites · doi:10.3390/metabo12050420 · Cited by 71
Martin, G., Beck, P.-L., & Sigalet, D.-L. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i26.4117 · Cited by 85
Furuse, M., Matsumoto, M., OKUMURA, J., Sugahara, K., & Hasegawa, S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00190-x · Cited by 77
Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide
Meier, J. J., & Nauck, M. A. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.08.007 · Cited by 82
Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Gan, H.-W., Cerbone, M., & Dattani, M. T. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnad033 · Cited by 65
“Abbreviations: 5-HT, serotonin; α MSH, α -melanocyte stimulating hormone; ACTH, adrenocorticotropic hormone; AgRP, Agouti-related peptide; ARC, arcuate nucleus; AVP, arginine–vasopressin; BDNF, brain-derived neurotrophic factor; BMI, body mass index; CART, cocaine-and amphetamine-regulated transcript; CCK, cholecystok…”
InfluentialProglucagon-Derived Peptides as Therapeutics
Lafferty, R. A., O’Harte, F. P. M., Irwin, N., Gault, V. A., & Flatt, P. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689678 · Cited by 71
“GLP-1(1-36) HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR N/A (60)”
BackgroundInfluentialThe Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties
Irwin, D. M., Satkunarajah, M., Wen, Y., Brubaker, P. L., Pederson, R. A., & Wheeler, M. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7915 · Cited by 79
Renal catabolism of human glucagon-like peptides 1 and 2
Ruiz-Grande, C., Pintado, J., Alarcón, C., Castilla, C., Valverde, I., & López-Novoa, J. M. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-239 · Cited by 72
FEHMANN, H. C., & HABENER, J. F. (1991) · Endocrinology · doi:10.1210/endo-128-6-2880 · Cited by 73
Incretin‐based therapies – review of the physiology, pharmacology and emerging clinical experience
Martin, J. H., Deacon, C. F., Gorrell, M. D., & Prins, J. B. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02439.x · Cited by 76
Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine.
Buhl, T., Thim, L., Kofod, H., Orskov, C., Harling, H., & Holst, J. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68350-4 · Cited by 72
Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1
Hellström, P. M., & Näslund, E. B. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00618-7 · Cited by 78
“Both peptides are released in equimolar amounts after food intake [46,47].”
BackgroundHolst, J. J., Albrechtsen, N. J. W., Rosenkilde, M. M., & Deacon, C. F. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180013 · Cited by 54
de Heer, J., Pedersen, J., Ørskov, C., & Holst, J. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0761-6 · Cited by 69
“GLP-1, are encoded within the glucagon gene, and are released together from enteroendocrine L cells in response to nutrient ingestion [ 8 , 9]. Despite these similarities, the two peptides differ markedly in their action on the endocrine pancreas.”
BackgroundFukase, N., Igarashi, M., Takahashi, H., Manaka, H., Yamatani, K., Daimon, M., Tominaga, M., & Sasaki, H. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb01995.x · Cited by 69
Vasoactive Intestinal Polypeptide and Related Peptides. Isolation and Chemistrya
Mutt, V. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb26968.x · Cited by 69
Effect of glucagon-like peptide-1 on insulin secretion
Shima, K., Hirota, M., & Ohboshi, C. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90037-7 · Cited by 79
Islet Cell Replication and Diabetes
Hellerström, C., Swenne, I., & Andersson, A. (1988) · Springer eBooks · doi:10.1007/978-3-642-72691-0_9 · Cited by 72
The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity
Crane, J., & McGowan, B. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622315620180 · Cited by 59
“Endogenous GLP-1 was discovered in the early 1980s [Bell et al. 1983] and was shown to act as an incretin at physiological concentrations [Kreymann et al.”
BackgroundImmunoassays for the incretin hormones GIP and GLP-1
Deacon, C. F., & Holst, J. J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.006 · Cited by 81
Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury
Matheeussen, V., Jungraithmayr, W., & Meester, I. D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.012 · Cited by 69
Cui, Y., Elahi, D., & Andersen, D. K. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1585-8 · Cited by 67
Ranganath, L. R. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043232 · Cited by 66
Wettergren, A., Pridal, L., Wøjdemann, M., & Holst, J. J. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00044-5 · Cited by 76
Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin
Fehmann, H. C., Göke, R., & Göke, B. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90118-p · Cited by 78
Obesity treatment: novel peripheral targets
Field, B. C. T., Chaudhri, O. B., & Bloom, S. R. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03522.x · Cited by 64
Uttenthal, L. O., & Blázquez, E. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80173-g · Cited by 65
Metadata
- Authors
- Bell, G. I., Santerre, R. F., & Mullenbach, G. T.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1983-04
- Volume
- 302
- Issue
- 5910
- Pages
- 716-718
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2061274996
- Cited by
- 649
- References
- 35
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 22 · 2023: 9 · 2022: 16 · 2021: 20 · 2020: 8 · 2019: 16 · 2018: 16 · 2017: 8 · 2016: 18 · 2015: 13 · 2014: 21 · 2013: 12 · 2012: 9
- FWCI
- 41.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proglucagon, glucagon, hamster, pancreatic A cells, cDNA sequence, precursor processing
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Fishes, Glucagon, Cricetinae, Molecular Weight, Protein Precursors, RNA, Messenger, Species Specificity, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.